Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: Monteverde & Associates PC Reminds Investors of the Following Investigation

AAQL

NEW YORK, NY / ACCESSWIRE / October 30, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • Innophos Holdings, Inc (NASDAQ:IPHS) ("Innophos") related to its sale to Iris Parent LLC ("Iris"). Under the terms of the Agreement, each share of Innophos common stock will be converted into the right to receive $32.00 in cash per share of Innophos common stock owned. Click here for more information: https://www.monteverdelaw.com/case/innophos-holdings-inc. It is free and there is no cost or obligation to you.
  • Cision Ltd (NYSE:CISN) related to its sale to MJ23 UK Acquisition Limited. Under the terms of the Merger Agreement, each share of CISN will automatically be exchanged for the right to receive $10.00 in cash per CISN share owned. Click here for more information: https://www.monteverdelaw.com/case/cision-ltd. It is free and there is no cost or obligation to you.
  • Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) related to its sale to Alexion Pharmaceuticals, Inc. Under the terms of the Merger, Achillion shareholders will have the right to receive $6.30 in cash per each Achillion common stock owned. Click here for more information: https://www.monteverdelaw.com/case/achillion-pharmaceuticals-inc. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017 and 2018 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/564753/SHAREHOLDER-ALERT-Monteverde-Associates-PC-Reminds-Investors-of-the-Following-Investigation